{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:43:17Z","timestamp":1783406597937,"version":"3.54.6"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with hypertension have worse acute COVID-19 outcomes, but the long-term effects of SARS-CoV-2 infection is unclear. We conducted a retrospective cohort study of adults with hypertension and no prior cardiovascular events in the Montefiore Health System, comparing those with and without COVID-19 over up to 4.5 years post-infection. Outcomes included first-time myocardial infarction (MI), heart failure (HF), stroke, all-cause mortality, and major adverse cardiovascular events (MACE). Multivariate regression and inverse-probability weighting adjusted for demographics, comorbidities, socioeconomic status, and COVID-19 vaccination. Adjusted hazard ratios (HRs) with 95% confidence intervals were calculated. Sub-analyses examined hypertension stage and acute COVID-19 blood biomarkers in relation to outcomes. Among 75,180 hypertensive patients, hospitalized COVID-19 was associated with increased risk of first-time MI (adjusted HR\u2009=\u20091.40 [1.21\u20131.63]), HF (1.59 [1.45\u20131.75]), stroke (1.35 [1.17\u20131.57]), all-cause mortality (2.51 [2.17\u20132.90]), and MACE (1.65 [1.54\u20131.77]) compared to COVID-negative individuals. Non-hospitalized COVID-19 patients had elevated risks of HF (1.17 [1.06\u20131.30]) and MACE (1.14 [1.05\u20131.23]). Hospitalized COVID-19 was associated with an increase in MACE risk by 75% in those with normal blood pressure, and by 126% and 148% in those with elevated blood pressure and stage 1 hypertension, respectively. Abnormal C-reactive protein, creatinine, lactate dehydrogenase, D-dimer, hemoglobin, and neutrophil-to-lymphocyte ratio predicted higher MACE risk. COVID-19, irrespective of disease severity, puts hypertensive patients at greater risks of worse cardiovascular outcomes, especially those with more advanced hypertension. These findings underscore the importance of long-term cardiovascular monitoring in this vulnerable population.<\/jats:p>","DOI":"10.1038\/s41371-026-01147-4","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:53:58Z","timestamp":1775728438000},"page":"446-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 and cardiovascular outcomes in patients with pre-existing hypertension"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2231-0172","authenticated-orcid":false,"given":"Roham","family":"Hadidchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhani","family":"Pahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Mehrotra-Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-0730","authenticated-orcid":false,"given":"Ryan C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-2827","authenticated-orcid":false,"given":"Tim Q.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"crossref","unstructured":"Fryar CD, Kit B, Carroll MD, Afful J. Hypertension prevalence, awareness, treatment, and control among adults age 18 and older: United States, August 2021\u2013August 2023. NCHS Data Brief 2024.","DOI":"10.15620\/cdc:134503"},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: General aspects. Pharmacol Res. 2018;129:95\u201399.","journal-title":"Pharmacol Res"},{"key":"1147_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/5584_2016_99","volume":"956","author":"Y Kokubo","year":"2017","unstructured":"Kokubo Y, Matsumoto C. Hypertension is a risk factor for several types of heart disease: review of prospective studies. Adv Exp Med Biol. 2017;956:419\u201326.","journal-title":"Adv Exp Med Biol"},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"m3222","DOI":"10.1136\/bmj.m3222","volume":"370","author":"D Luo","year":"2020","unstructured":"Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H, et al. Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis. BMJ. 2020;370:m3222.","journal-title":"BMJ"},{"key":"1147_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285\u201392.","journal-title":"Hypertension"},{"key":"1147_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1095249","volume":"9","author":"FJ Allendes","year":"2022","unstructured":"Allendes FJ, Diaz HS, Ortiz FC, Marcus NJ, Quintanilla R, Inestrosa NC, et al. Cardiovascular and autonomic dysfunction in long-COVID syndrome and the potential role of non-invasive therapeutic strategies on cardiovascular outcomes. Front Med (Lausanne). 2022;9:1095249.","journal-title":"Front Med (Lausanne)"},{"key":"1147_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/d41586-022-00403-0","volume":"602","author":"SM Sidik","year":"2022","unstructured":"Sidik SM. Heart-disease risk soars after COVID - even with a mild case. Nature. 2022;602:560.","journal-title":"Nature"},{"key":"1147_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/HJH.0000000000004013","volume":"43","author":"S Lip","year":"2025","unstructured":"Lip S, Tran TQB, Hanna R, Nichol S, Guzik TJ, Delles C, et al. Long-term effects of SARS-CoV-2 infection on blood vessels and blood pressure - LOCHINVAR. J Hypertens. 2025;43:1057\u201365.","journal-title":"J Hypertens"},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejim.2023.10.016","volume":"119","author":"F Angeli","year":"2024","unstructured":"Angeli F, Zappa M, Verdecchia P. Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection. Eur J Intern Med. 2024;119:31\u201333.","journal-title":"Eur J Intern Med"},{"key":"1147_CR10","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1097\/HJH.0000000000003522","volume":"41","author":"C Schmidt-Lauber","year":"2023","unstructured":"Schmidt-Lauber C, Alba Schmidt E, Hanzelmann S, Petersen EL, Behrendt CA, Twerenbold R, et al. Increased blood pressure after nonsevere COVID-19. J Hypertens. 2023;41:1721\u20139.","journal-title":"J Hypertens"},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3390\/ijms25031837","volume":"25","author":"E Bielecka","year":"2024","unstructured":"Bielecka E, Sielatycki P, Pietraszko P, Zapora-Kurel A, Zbroch E. Elevated arterial blood pressure as a delayed complication following COVID-19-A narrative review. Int J Mol Sci. 2024;25:1837.","journal-title":"Int J Mol Sci"},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1161\/HYPERTENSIONAHA.123.21174","volume":"80","author":"V Zhang","year":"2023","unstructured":"Zhang V, Fisher M, Hou W, Zhang L, Duong TQ. Incidence of new-onset hypertension Post-COVID-19: comparison with influenza. Hypertension. 2023;80:2135\u201348.","journal-title":"Hypertension"},{"key":"1147_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/00015385.2021.1890925","volume":"77","author":"M Zuin","year":"2022","unstructured":"Zuin M, Rigatelli G, Bilato C, Zuliani G, Roncon L. Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis. Acta Cardiol. 2022;77:107\u201313.","journal-title":"Acta Cardiol"},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/23969873231190432","volume":"8","author":"M Zuin","year":"2023","unstructured":"Zuin M, Mazzitelli M, Rigatelli G, Bilato C, Cattelan AM. Risk of ischemic stroke in patients recovered from COVID-19 infection: A systematic review and meta-analysis. Eur Stroke J. 2023;8:915\u201322.","journal-title":"Eur Stroke J"},{"key":"1147_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10741-022-10292-0","volume":"28","author":"M Zuin","year":"2023","unstructured":"Zuin M, Rigatelli G, Roncon L, Pasquetto G, Bilato C. Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis. Heart Fail Rev. 2023;28:859\u201364.","journal-title":"Heart Fail Rev"},{"key":"1147_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2022.12.032","volume":"372","author":"M Zuin","year":"2023","unstructured":"Zuin M, Rigatelli G, Battisti V, Costola G, Roncon L, Bilato C. Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis. Int J Cardiol. 2023;372:138\u201343.","journal-title":"Int J Cardiol"},{"key":"1147_CR17","doi-asserted-by":"publisher","first-page":"9309","DOI":"10.3390\/ijms21239309","volume":"21","author":"J Maiuolo","year":"2020","unstructured":"Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, et al. The contribution of endothelial dysfunction in systemic injury subsequent to SARS-Cov-2 infection. Int J Mol Sci. 2020;21:9309.","journal-title":"Int J Mol Sci"},{"key":"1147_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03062-7","volume":"24","author":"S Pons","year":"2020","unstructured":"Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24:353.","journal-title":"Crit Care"},{"key":"1147_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2025.123477","volume":"473","author":"R Hadidchi","year":"2025","unstructured":"Hadidchi R, Al-Ani Y, Choi S, Renteria S, Duong KS, Henry S, et al. Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection. J Neurol Sci. 2025;473:123477.","journal-title":"J Neurol Sci"},{"key":"1147_CR20","doi-asserted-by":"crossref","unstructured":"Hadidchi R, Al-Ani Y, Piskun H, Pakan R, Duong K, Jamil H, et al. Long-term outcomes of patients with Parkinson\u2019s disease 3.5 years post SARS-CoV-2 infection in an inner-city population in the Bronx. Eur J Neurology 2025;32:e70013.","DOI":"10.21203\/rs.3.rs-4373059\/v1"},{"key":"1147_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70013","volume":"32","author":"R Hadidchi","year":"2025","unstructured":"Hadidchi R, Al-Ani Y, Piskun H, Pakan R, Duong KS, Jamil H, et al. Impact of COVID-19 on long-term outcomes in Parkinson\u2019s disease. Eur J Neurol. 2025;32:e70013.","journal-title":"Eur J Neurol"},{"key":"1147_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-025-07713-7","volume":"212","author":"R Hadidchi","year":"2025","unstructured":"Hadidchi R, Duong KS, Hou J, Maldjian T, Chung J, Hou W, et al. COVID-19 pandemic interruption of breast cancer screening is linked to clinical upstaging at presentation: the roles of demographics, socioeconomic status and unmet social needs. Breast Cancer Res Treat. 2025;212:205\u201316.","journal-title":"Breast Cancer Res Treat"},{"key":"1147_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105778","volume":"116","author":"R Hadidchi","year":"2025","unstructured":"Hadidchi R, Lee P, Qiu S, Changela S, Henry S, Duong TQ. Long-term outcomes of patients with pre-existing coronary artery disease after SARS-CoV-2 infection. EBioMedicine. 2025;116:105778.","journal-title":"EBioMedicine"},{"key":"1147_CR24","doi-asserted-by":"crossref","unstructured":"Hadidchi R, Pakan R, Alamuri T, Cercizi N, Al-Ani Y, Wang SH, et al. Long COVID-19 outcomes of patients with pre-existing dementia. J Alzheimers Dis 2024;103:605\u2013615.","DOI":"10.1177\/13872877241303934"},{"key":"1147_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105613","volume":"86","author":"R Hadidchi","year":"2024","unstructured":"Hadidchi R, Wang SH, Rezko D, Henry S, Coyle PK, Duong TQ. SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population. Mult Scler Relat Disord. 2024;86:105613.","journal-title":"Mult Scler Relat Disord"},{"key":"1147_CR26","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.3390\/diagnostics14242774","volume":"14","author":"R Pakan","year":"2024","unstructured":"Pakan R, Hadidchi R, Al-Ani Y, Piskun H, Duong KS, Henry S, et al. Long-Term outcomes of patients with pre-existing essential tremor after SARS-CoV-2 infection. Diagnostics. 2024;14:2774.","journal-title":"Diagnostics"},{"key":"1147_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/diagnostics15091091","volume":"15","author":"S Qiu","year":"2025","unstructured":"Qiu S, Hadidchi R, Vichare A, Lu JY, Hou W, Henry S, et al. SARS-CoV-2 infection is associated with an accelerated eGFR decline in kidney transplant recipients up to four years post infection. Diagnostics. 2025;15:1091.","journal-title":"Diagnostics"},{"key":"1147_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103821","volume":"76","author":"JQ Lu","year":"2022","unstructured":"Lu JQ, Lu JY, Wang W, Liu Y, Buczek A, Fleysher R, et al. Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19. EBioMedicine. 2022;76:103821.","journal-title":"EBioMedicine"},{"key":"1147_CR29","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/ndt\/gfad020","volume":"38","author":"JY Lu","year":"2023","unstructured":"Lu JY, Boparai MS, Shi C, Henninger EM, Rangareddy M, Veeraraghavan S, et al. Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI. Nephrol Dial Transplant. 2023;38:2160\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1147_CR30","doi-asserted-by":"publisher","first-page":"798897","DOI":"10.3389\/fcvm.2021.798897","volume":"8","author":"JY Lu","year":"2021","unstructured":"Lu JY, Buczek A, Fleysher R, Hoogenboom WS, Hou W, Rodriguez CJ, et al. Outcomes of hospitalized patients with COVID-19 with acute kidney injury and acute cardiac injury. Front Cardiovasc Med. 2021;8:798897.","journal-title":"Front Cardiovasc Med"},{"key":"1147_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15277","volume":"9","author":"JY Lu","year":"2023","unstructured":"Lu JY, Buczek A, Fleysher R, Musheyev B, Henninger EM, Jabbery K, et al. Characteristics of COVID-19 patients with multiorgan injury across the pandemic in a large academic health system in the Bronx, New York. Heliyon. 2023;9:e15277.","journal-title":"Heliyon"},{"key":"1147_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22741-9","volume":"12","author":"JY Lu","year":"2022","unstructured":"Lu JY, Ho SL, Buczek A, Fleysher R, Hou W, Chacko K, et al. Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge. Sci Rep. 2022;12:17972.","journal-title":"Sci Rep"},{"key":"1147_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s15010-021-01646-1","volume":"50","author":"JY Lu","year":"2022","unstructured":"Lu JY, Hou W, Duong TQ. Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study. Infection. 2022;50:109\u201319.","journal-title":"Infection"},{"key":"1147_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82983-7","volume":"14","author":"JY Lu","year":"2024","unstructured":"Lu JY, Lu JY, Wang SH, Duong KS, Hou W, Duong TQ. New-onset cardiovascular diseases post SARS-CoV-2 infection in an urban population in the Bronx. Sci Rep. 2024;14:31451.","journal-title":"Sci Rep"},{"key":"1147_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104487","volume":"90","author":"JY Lu","year":"2023","unstructured":"Lu JY, Wilson J, Hou W, Fleysher R, Herold BC, Herold KC, et al. Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. EBioMedicine. 2023;90:104487.","journal-title":"EBioMedicine"},{"key":"1147_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58430-y","volume":"14","author":"A Eligulashvili","year":"2024","unstructured":"Eligulashvili A, Darrell M, Gordon M, Jerome W, Fiori KP, Congdon S, et al. Patients with unmet social needs are at higher risks of developing severe long COVID-19 symptoms and neuropsychiatric sequela. Sci Rep. 2024;14:7743.","journal-title":"Sci Rep"},{"key":"1147_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/diagnostics13010119","volume":"13","author":"A Eligulashvili","year":"2022","unstructured":"Eligulashvili A, Darrell M, Miller C, Lee J, Congdon S, Lee JS, et al. COVID-19 patients in the COVID-19 recovery and engagement (CORE) clinics in the Bronx. Diagnostics (Basel). 2022;13:119.","journal-title":"Diagnostics (Basel)"},{"key":"1147_CR38","doi-asserted-by":"publisher","first-page":"e1004263","DOI":"10.1371\/journal.pmed.1004263","volume":"21","author":"A Eligulashvili","year":"2024","unstructured":"Eligulashvili A, Gordon M, Lee JS, Lee J, Mehrotra-Varma S, Mehrotra-Varma J, et al. Long-term outcomes of hospitalized patients with SARS-CoV-2\/COVID-19 with and without neurological involvement: 3-year follow-up assessment. PLoS Med. 2024;21:e1004263.","journal-title":"PLoS Med"},{"key":"1147_CR39","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18481","volume":"12","author":"A Eligulashvili","year":"2024","unstructured":"Eligulashvili A, Gordon M, Nemerofsky S, Havranek T, Bernstein P, Yee J, et al. Physical development of infants born to patients with COVID-19 during pregnancy: 2 years of age. PeerJ. 2024;12:e18481.","journal-title":"PeerJ"},{"key":"1147_CR40","doi-asserted-by":"publisher","first-page":"106212","DOI":"10.1016\/j.ebiom.2026.106212","volume":"126","author":"SS Henry","year":"2026","unstructured":"Henry SS, Duong KE, Duong TQ.\u00a0Long-term impact of SARS-CoV-2on recurrent COPD exacerbations.\u00a0EBiomedicine 2026;126:106212.","journal-title":"EBiomedicine"},{"key":"1147_CR41","doi-asserted-by":"crossref","unstructured":"Henry SS, Duong KE, Cabana MD, Duong TQ. Effects of COVID-19 pandemic on incidence of asthma exacerbation in an urban population. Sci Rep. 2026;16:10352.","DOI":"10.1038\/s41598-026-41311-x"},{"key":"1147_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06625-w","volume":"23","author":"R Hadidchi","year":"2025","unstructured":"Hadidchi R, Patel B, Madan J, Liu A, Henry S, Duong TQ. Elevated risk of new-onset chronic fatigue syndrome\/myalgic encephalomyelitis up to four years after SARS-CoV-2 infection. J Transl Med. 2025;23:815.","journal-title":"J Transl Med"},{"key":"1147_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.043976","volume":"14","author":"R Hadidchi","year":"2025","unstructured":"Hadidchi R, Ali E, Piskun H, Henry S, Zhang L, Duong TQ. Elevated risk of long-term decline in left ventricular ejection fraction after COVID-19. J Am Heart Assoc. 2025;14:e043976.","journal-title":"J Am Heart Assoc"},{"key":"1147_CR44","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/diagnostics15202605","volume":"15","author":"S Changela","year":"2025","unstructured":"Changela S, Hadidchi R, Wu S, Ali E, Liu A, Peng T, et al. Incidence of anxiety diagnosis up to four years post SARS-CoV-2 infection in the montefiore medical center in the Bronx and New York. Diagnostics (Basel). 2025;15:2605.","journal-title":"Diagnostics (Basel)"},{"key":"1147_CR45","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/diagnostics15243183","volume":"15","author":"S Changela","year":"2025","unstructured":"Changela S, Hadidchi R, Vichare A, Rahmani L, Henry S, Duong TQ. Risks of stroke and transient cerebral ischemia up to 4 years Post-SARS-CoV-2 infection in large diverse urban population in the Bronx. Diagnostics (Basel). 2025;15:3183.","journal-title":"Diagnostics (Basel)"},{"key":"1147_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/diagnostics16010038","volume":"16","author":"S Pahuja","year":"2025","unstructured":"Pahuja S, Hadidchi R, Tonge J, Henry S, Duong TQ. Long-Term cardiovascular and mortality risk in patients with pre-existing arrhythmia Post-SARS-CoV-2 infection. Diagnostics (Basel). 2025;16:38.","journal-title":"Diagnostics (Basel)"},{"key":"1147_CR47","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127\u2013e248.","journal-title":"J Am Coll Cardiol"},{"key":"1147_CR48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/pathogens12080973","volume":"12","author":"A Russo","year":"2023","unstructured":"Russo A, Pisaturo M, Monari C, Ciminelli F, Maggi P, Allegorico E, et al. Prognostic value of creatinine levels at admission on disease progression and mortality in patients with COVID-19-An observational retrospective study. Pathogens. 2023;12:973.","journal-title":"Pathogens"},{"key":"1147_CR49","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","volume":"2","author":"BJ Webb","year":"2020","unstructured":"Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, et al. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. 2020;2:e754\u2013e763.","journal-title":"Lancet Rheumatol"},{"key":"1147_CR50","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017;36:4391\u20134400.","journal-title":"Stat Med"},{"key":"1147_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/pds.1200","volume":"15","author":"S Schneeweiss","year":"2006","unstructured":"Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf. 2006;15:291\u2013303.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1147_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583\u201390.","journal-title":"Nat Med"},{"key":"1147_CR53","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/v15020508","volume":"15","author":"I Vosko","year":"2023","unstructured":"Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on cardiovascular disease. Viruses. 2023;15:508.","journal-title":"Viruses"},{"key":"1147_CR54","first-page":"4509","volume":"26","author":"S Parvu","year":"2022","unstructured":"Parvu S, Muller K, Dahdal D, Cosmin I, Christodorescu R, Duda-Seiman D, et al. COVID-19 and cardiovascular manifestations. Eur Rev Med Pharmacol Sci. 2022;26:4509\u201319.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1147_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106215","volume":"89","author":"K Romero Starke","year":"2024","unstructured":"Romero Starke K, Kaboth P, Rath N, Reissig D, Kaempf D, Nienhaus A, et al. Cardiovascular disease risk after a SARS-CoV-2 infection: A systematic review and meta-analysis. J Infect. 2024;89:106215.","journal-title":"J Infect"},{"key":"1147_CR56","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.3390\/ijms22094526","volume":"22","author":"A Aleksova","year":"2021","unstructured":"Aleksova A, Gagno G, Sinagra G, Beltrami AP, Janjusevic M, Ippolito G, et al. Effects of SARS-CoV-2 on cardiovascular system: the dual role of angiotensin-converting Enzyme 2 (ACE2) as the virus receptor and homeostasis regulator-review. Int J Mol Sci. 2021;22:4526.","journal-title":"Int J Mol Sci"},{"key":"1147_CR57","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456\u201374.","journal-title":"Circ Res"},{"key":"1147_CR58","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.3390\/molecules26226945","volume":"26","author":"G El-Arif","year":"2021","unstructured":"El-Arif G, Farhat A, Khazaal S, Annweiler C, Kovacic H, Wu Y, et al. The renin-angiotensin system: a key role in SARS-CoV-2-Induced COVID-19. Molecules. 2021;26:6945.","journal-title":"Molecules"},{"key":"1147_CR59","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1038\/s41440-025-02229-5","volume":"48","author":"SI Miura","year":"2025","unstructured":"Miura SI, Matsuo Y, Seumatsu Y. Renin-angiotensin-aldosterone system and its relation to hypertension. Hypertens Res. 2025;48:2209\u201317.","journal-title":"Hypertens Res"},{"key":"1147_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108701","volume":"163","author":"MT Abdel Ghafar","year":"2020","unstructured":"Abdel Ghafar MT. An overview of the classical and tissue-derived renin-angiotensin-aldosterone system and its genetic polymorphisms in essential hypertension. Steroids. 2020;163:108701.","journal-title":"Steroids"},{"key":"1147_CR61","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666\u201387.","journal-title":"Cardiovasc Res"},{"key":"1147_CR62","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.jacc.2020.08.059","volume":"76","author":"G Giustino","year":"2020","unstructured":"Giustino G, Pinney SP, Lala A, Reddy VY, Johnston-Cox HA, Mechanick JI, et al. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar. J Am Coll Cardiol. 2020;76:2011\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"1147_CR63","first-page":"726","volume":"39","author":"P Parhizgar","year":"2023","unstructured":"Parhizgar P, Yazdankhah N, Rzepka AM, Chung KYC, Ali I, Lai Fat Fur R, et al. Beyond acute COVID-19: a review of long-term cardiovascular outcomes. Can J Cardiol. 2023;39:726\u201340.","journal-title":"Can J Cardiol"},{"key":"1147_CR64","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1038\/s41591-022-02000-0","volume":"28","author":"VO Puntmann","year":"2022","unstructured":"Puntmann VO, Martin S, Shchendrygina A, Hoffmann J, Ka MM, Giokoglu E, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28:2117\u201323.","journal-title":"Nat Med"},{"key":"1147_CR65","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/00273170802285941","volume":"43","author":"L Wang","year":"2009","unstructured":"Wang L, Zhang Z, McArdle JJ, Salthouse TA. Investigating ceiling effects in longitudinal data analysis. Multivariate Behav Res. 2009;43:476\u201396.","journal-title":"Multivariate Behav Res"},{"key":"1147_CR66","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1161\/HYP.0000000000000232","volume":"80","author":"M Abdalla","year":"2023","unstructured":"Abdalla M, Bolen SD, Brettler J, Egan BM, Ferdinand KC, Ford CD, et al. Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association. Hypertension. 2023;80:e143\u2013e157.","journal-title":"Hypertension"},{"key":"1147_CR67","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.122.20219","volume":"80","author":"OP Akinyelure","year":"2023","unstructured":"Akinyelure OP, Jaeger BC, Oparil S, Carson AP, Safford MM, Howard G, et al. Social determinants of health and uncontrolled blood pressure in a national cohort of black and white US Adults: the REGARDS Study. Hypertension. 2023;80:1403\u201313.","journal-title":"Hypertension"},{"key":"1147_CR68","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.7326\/M23-2109","volume":"176","author":"M Liu","year":"2023","unstructured":"Liu M, Aggarwal R, Zheng Z, Yeh RW, Kazi DS, Joynt Maddox KE, et al. Cardiovascular health of middle-aged U.S. adults by income level, 1999 to March 2020: a serial cross-sectional study. Ann Intern Med. 2023;176:1595\u2013605.","journal-title":"Ann Intern Med"},{"key":"1147_CR69","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.amepre.2022.11.002","volume":"64","author":"N Huguet","year":"2023","unstructured":"Huguet N, Green BB, Voss RW, Larson AE, Angier H, Miguel M, et al. Factors associated with blood pressure control among patients in community health centers. Am J Prev Med. 2023;64:631\u201341.","journal-title":"Am J Prev Med"},{"key":"1147_CR70","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciac772","volume":"76","author":"DR Boulware","year":"2023","unstructured":"Boulware DR, Murray TA, Proper JL, Tignanelli CJ, Buse JB, Liebovitz DM, et al. Impact of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) vaccination and booster on Coronavirus disease 2019 (COVID-19) symptom severity over time in the COVID-OUT trial. Clin Infect Dis. 2023;76:e1\u2013e9.","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01147-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:02:52Z","timestamp":1781042572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01147-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01147-4","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. This study used deidentified EHR data from the Montefiore Health System. Einstein-Montefiore Institutional Review Board (#2021-13658) approved this study with an exemption for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}